In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Biomarin Pharmaceutical Inc (BMRN) stock saw a modest uptick, ending the day at $61.8 which represents a slight increase of $0.07 or 0.11% from the prior close of $61.73. The stock opened at $62.1 and ...

A member of a grant review panel explains the ins and outs of applying for research funding – and the consequences of when ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

Wedbush upped their FY2024 EPS estimates for Ultragenyx Pharmaceutical in a report released on Thursday, January 23rd. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will ...

Scientist and pharmaceutical researcher Andrew P. Mallon—who first reported to NIH and others in 2016 his suspicions that then-Athira Pharma CEO ...

Advances in Experimental Pharmacology and Drug Discovery have encountered a crucial but often overlooked challenge: gender inequality. Despite the pivotal ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has ...

UC Santa Cruz has announced the Innovation Catalyst Grant proof-of-concept program awardees, showcasing the campus’s ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...